Use of nilotinib in the diabetic patient
A 42-year-old man, diabetic patient, after CML Ph+ diagnosis started a treatment with imatinib reaching both CHR and CCyR within 6 months. Because of two episodes of vitreous haemorrhage the treatment was discontinued for four months with the lost of the CCyR and the maintenance of the CHR. The pati...
Na minha lista:
| Autor principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SEEd
2015-10-01
|
| coleção: | Clinical Management Issues |
| Assuntos: | |
| Acesso em linha: | https://journals.seedmedicalpublishers.com/index.php/cmi/article/view/1094 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|